PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.\', \'Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.\', \'Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC.\', \'Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC; and.\', \'Biological and Biomedical Sciences Program, University of North Carolina at Chapel Hill, Chapel Hill, NC.\', \'Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; jenny_ting@med.unc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.4049/jimmunol.2001287
?:hasPublicationType
?:journal
  • Journal of immunology (Baltimore, Md. : 1950)
is ?:pmid of
?:pmid
?:pmid
  • 34021048
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Influenza Virus and SARS-CoV-2 Vaccines.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all